- Home
- News
- Articles+
- Aerospace
- Artificial Intelligence
- Agriculture
- Alternate Dispute Resolution
- Arbitration & Mediation
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- Environmental, Social, and Governance
- Foreign Direct Investment
- Food and Beverage
- Gaming
- Health Care
- IBC Diaries
- In Focus
- Inclusion & Diversity
- Insurance Law
- Intellectual Property
- International Law
- IP & Tech Era
- Know the Law
- Labour Laws
- Law & Policy and Regulation
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Student Corner
- Take On Board
- Tax
- Technology Media and Telecom
- Tributes
- Viewpoint
- Zoom In
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- Middle East
- Africa
- News
- Articles
- Aerospace
- Artificial Intelligence
- Agriculture
- Alternate Dispute Resolution
- Arbitration & Mediation
- Banking and Finance
- Bankruptcy
- Book Review
- Bribery & Corruption
- Commercial Litigation
- Competition Law
- Conference Reports
- Consumer Products
- Contract
- Corporate Governance
- Corporate Law
- Covid-19
- Cryptocurrency
- Cybersecurity
- Data Protection
- Defence
- Digital Economy
- E-commerce
- Employment Law
- Energy and Natural Resources
- Entertainment and Sports Law
- Environmental Law
- Environmental, Social, and Governance
- Foreign Direct Investment
- Food and Beverage
- Gaming
- Health Care
- IBC Diaries
- In Focus
- Inclusion & Diversity
- Insurance Law
- Intellectual Property
- International Law
- IP & Tech Era
- Know the Law
- Labour Laws
- Law & Policy and Regulation
- Litigation
- Litigation Funding
- Manufacturing
- Mergers & Acquisitions
- NFTs
- Privacy
- Private Equity
- Project Finance
- Real Estate
- Risk and Compliance
- Student Corner
- Take On Board
- Tax
- Technology Media and Telecom
- Tributes
- Viewpoint
- Zoom In
- Law Firms
- In-House
- Rankings
- E-Magazine
- Legal Era TV
- Events
- Middle East
- Africa
Suraj Sinha

From Suraj Sinha
SEBI Announces Settlement Scheme For Venture Capital Funds From 21 July
Offers an opportunity to settle matters by 19 July
Panasonic Postpones EV Battery Plant’s Operation In US
Cites its main customer, Tesla’s sluggish sales as the reason for the decision
Bombay High Court Seeks SEBI’s Response On Kirloskar Group’s Plea Challenging Amendment Norms
The final hearing will be held on 20 August
Bike Taxis A Necessity, Not Luxury: Ola, Uber, Rapido Tell Karnataka High Court
The next hearing has been scheduled for 2 July
Gautam Adani’s Ingenious Plan Focuses On Nation-Building
Announces Rs.60,000 crores push through healthcare, skilling and spiritual collaboration
‘No Obstacle In NSE IPO’: SEBI Chairman Tuhin Kanta Pandey
He was speaking at the Financial Express CFO Awards
Amid Stable Liquidity, RBI Junks VRR Auction Third Time In A Row
The move signifies the central bank’s trust in the structure’s fluidity
Mandatory Online Payment of License Fees Proposed by Ministry of Commerce
The main difference between the two provisions is that the existing rule prescribes fees payable to the Copyright Office
Delhi High Court Grants Injunction Against ‘Amuleti’ In Favor Of Amul
The Delhi High Court emphasised that Italian firm Terre Primitive had "blatantly" imitated the script, design, and overall
SEBI Approves MCX Proposal To Launch Electricity Derivatives
It will enhance efficiency in the power market
ED Searches Alderbrooke Portfolio’s Offices For Operating Sans SEBI Registration
The probe was carried out under the provisions of the Prevention of Money Laundering Act
Fda Approves Gsk’s Asthma Drug Nucala For Smoker’s Lung Treatment
GSK’s asthma drug, Nucala, has received FDA approval to treat ‘smoker’s lung,’ expanding its use as an add-on treatment












